Skip to content

Gene Expression During an Energy Restricted Weight loss Diet

A randomized parallel study to investigate the effect of high and standard protein content on gene expression in skeletal muscle and adipose tissue in overweight/obese women.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000385246
Acronym
GE
Enrollment
16
Registered
2009-05-29
Start date
2009-04-14
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The prevalence of overweight and obese individuals has significantly increased in Australia over the past 20-30 years. Associated with high body mass is the increased the risks of type II diabetes, cardiovascular disease, high blood pressure, certain cancers, sleep apnoea, osteoarthritis, psychological disorders and social problems.Overall, the aim of this study is to examine the gene changes during weight loss and identify the potential gene targets of a high-protein diet that may be important for preservation of muscle mass. Different protein preparations could then be tested looking specifically at these gene changes. Those protein preparations identified as important for preservation of muscle mass will be reported as a beneficial inclusion in high-protein weight loss and may ‘aid’ in the maintenance of long-term weight reduction.

Interventions

Intervention of fortnightly consultation with a dietitian, providing meal plans and advice aiming for the consumption of 1500 calories (6000 kJ/day)of either a high-protein or a high-carbohydrate diet for 12 weeks.

Sponsors

CSIRO Human Nutrition
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Female, Aged between 40-60 years old, Body Mass Index (BMI) not greater than 40 or less than 27. Not currently participating in an exercise or weight loss program. Participants must understand the procedures involved and agree to participate in the study by giving full informed, written consent

Exclusion criteria

Previously diagnosed or currently taking hypoglycaemic medication for Type 1 or 2 diabetes, Fasting blood glucose of > 7.0 mmol/L, Known allergy to anesthetics, Any abnormality of clinical significance on medical history, Currently pregnant, planning pregnancy or breastfeeding, Currently participating in a physical activity program, Currently taking a caloric restricted diet, Taking antihypertensive or cholesterol-lowering medication e.g. Lipitor, Xenical, Zetia or Hyperium. Proteinuria, a malignancy, or a history of metabolic disease such as liver, kidney, cardiovascular, respiratory or gastrointestinal disease, Cardiac (heart) abnormalit(y)ies, Cigarette smoker within 6 months prior to study commencement, Regular heavy alcohol consumption (> 5 standard drinks/day).

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026